Pharmacologic Pain Management

Phase 3Small molecule

UUniversity of California, San Francisco

Pharmacologic Pain Management is one of 3 small molecule programs targeting Postsurgical Pain Management. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Postsurgical Pain ManagementNot yet recruiting

Postsurgical Pain ManagementPhase 3

Not yet recruiting

Competition

Competitive Landscape

2 competitors in Postsurgical Pain Management

#DrugCompanyPhaseTrials

TLC590

TTLC Biopharmaceuticals, Inc.

Phase 3

3 2

Pharmacologic Pain Management

UUniversity of California, San Francisco

Phase 3

1 3

Blank Preparation.

FFujian Shengdi Pharmaceutical Co., Ltd.

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2028

Phase 3Not yet recruiting

Postsurgical Pain Management

NCT07296770

Clinical

Trials by Indication[1]

Postsurgical Pain Management1 trial

An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service

Not yet recruiting·UUniversity of California, San Francisco·Phase 3·NCT07296770·126 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Pharmacologic Pain Management. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Pharmacologic Pain Management compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Pharmacologic Pain Management. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of California, San Francisco company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity of California, San Francisco

Pharmacologic Pain Management

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2028

Trials by Indication[1]

Postsurgical Pain Management1 trial

References

Drug Info

Quick Facts

Related News